Crystal forms of (R) - N-methylnaltrexone bromide and uses thereof

Details for Australian Patent Application No. 2008233133 (hide)

Owner Progenics Pharmaceuticals, Inc.

Inventors Perez, Julio; Boyd, Thomas A.; Ali, Kadum A.; Shah, Syed M.; Smolenskaya, Valeriya N.

Agent Pizzeys

Pub. Number AU-A-2008233133

PCT Pub. Number WO2008/121352

Priority 60/921,111 29.03.07 US

Filing date 28 March 2008

Wipo publication date 9 October 2008

International Classifications

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 489/04 (2006.01) Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:

Event Publications

22 October 2009 PCT application entered the National Phase

  PCT publication WO2008/121352 Priority application(s): WO2008/121352

19 November 2009 Amendment Made

  The nature of the amendment is: Amend applicant name to include co-applicant Wyeth

5 August 2010 Alteration of Name

  The name of the applicant has been altered to Progenics Pharmaceuticals, Inc.; Wyeth LLC

4 November 2010 Amendment Made

  The nature of the amendment is: Amend co-inventor name from Ali, Kadum A. to Al Shareffi, Kadum A.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008233139-System for color match and digital color display

2008233129-Peripheral opioid receptor antagonists and uses thereof